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Marie-Pierre Ryser-DegiorgisAbstract
In a fast changing world with growing concerns about biodiversity loss and an increasing number of animal and
human diseases emerging from wildlife, the need for effective wildlife health investigations including both
surveillance and research is now widely recognized. However, procedures applicable to and knowledge acquired
from studies related to domestic animal and human health can be on partly extrapolated to wildlife. This article
identifies requirements and challenges inherent in wildlife health investigations, reviews important definitions and
novel health investigation methods, and proposes tools and strategies for effective wildlife health surveillance
programs. Impediments to wildlife health investigations are largely related to zoological, behavioral and ecological
characteristics of wildlife populations and to limited access to investigation materials. These concerns should not be
viewed as insurmountable but it is imperative that they are considered in study design, data analysis and result
interpretation. It is particularly crucial to remember that health surveillance does not begin in the laboratory but in
the fields. In this context, participatory approaches and mutual respect are essential. Furthermore, interdisciplinarity
and open minds are necessary because a wide range of tools and knowledge from different fields need to be
integrated in wildlife health surveillance and research. The identification of factors contributing to disease
emergence requires the comparison of health and ecological data over time and among geographical regions.
Finally, there is a need for the development and validation of diagnostic tests for wildlife species and for data on
free-ranging population densities. Training of health professionals in wildlife diseases should also be improved.
Overall, the article particularly emphasizes five needs of wildlife health investigations: communication and collabor-
ation; use of synergies and triangulation approaches; investments for the long term; systematic collection of meta-
data; and harmonization of definitions and methods.
Keywords: Collaboration, Definitions, Harmonization, Health, Impediments, Surveillance, Strategies, Risk factors,
Tools, WildlifeIntroduction
Growing human population, globalization, climate change
and a number of ecological perturbations have resulted in
an increasing number of emerging diseases. Given this
context, the role of wildlife in human and domestic animal
disease emergence has become widely recognized as a fac-
tor we can no longer afford to ignore. Thus, wildlife health
surveillance has become an integral component in the
identification and management of potential threats to hu-
man and animal health [1-4]. The objectives, concepts
and methodology of investigations into wildlife health are
similar to those of domestic animal health surveillance.Correspondence: marie-pierre.ryser@vetsuisse.unibe.ch
Centre for Fish and Wildlife Health, Vetsuisse Faculty, University of Bern,
Postfach 8466, CH-3001 Bern, Switzerland
© 2013 Ryser-Degiorgis; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the orBut given the zoological, behavioral and ecological charac-
teristics of wildlife populations, there are also some sub-
stantial differences that need to be taken into account
when planning for, implementing and interpreting data
from investigations into wildlife health. It requires a new
set of definitions, methods and procedures, taking into ac-
count the unique conditions under which wildlife health
surveillance is carried out [5]. Laboratories still tend to
rely on domestic animal surveillance approaches in their
investigations into wildlife pathogens. It is important to
stress that although the growing interest in wildlife health
is definitely a positive trend, this reliance bears a substan-
tial risk of error at various levels ranging from initial study
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tigating the health of free-ranging wildlife, including the
challenges and constraints inherent in such investiga-
tions, with a particular focus on surveillance. The aims
are to provide: (1) revised definitions of old concepts; (2)
an update on the importance of influencing factors on
wildlife health investigations; (3) an overview of tools
available to wildlife health investigators.
Health, disease and pathogen: modern definitions
The World Health Organization (WHO) has defined
health as a “state of complete physical, mental and social
well-being and not merely the absence of disease or in-
firmity” [6], which implies that most humans are un-
healthy most of the time. In veterinary medicine, health
has been defined as “a state of physical and psychological
well-being and of productivity, including reproduction”
and “health indices” refer to easily observed parameters
that can be used as a guide to the animal’s or group’s state
of health (e.g., food intake, fecal output, body weight) [7].
It has recently been proposed to redefine health as “the
ability to adapt and to self-manage” [8,9], i.e., an organism
is healthy if it is capable of maintaining physiological
homeostasis through changing circumstances. If it is un-
able to mount a protective response, reducing the poten-
tial for harm and restoring an (adapted) equilibrium,
damage remains and may result in illness [9]. Accordingly,
measuring health is challenging and requires tools for
assessing an individual’s capacity to cope and to adapt. It
is also important to differentiate between the health status
of individuals and that of populations [9].
Population health has emerged as an important discip-
line. In veterinary medicine it is particularly useful in the
assessment of production animal health and wildlife
health. Population health is concerned with the definition
and measurement of health outcomes (the dependent var-
iables) and the roles of determinants (the independent
variables). The term “health outcome” is preferred over
“health status”, because the latter refers to health at a
point in time rather than to health over a period of years
[10]. A hallmark of the field of population health is signifi-
cant attention to the multiple determinants of health out-
comes and their interactions, i.e., examining: systematic
differences in outcomes across populations; the complex-
ity of interactions among determinants; the biological
pathways linking determinants to population health out-
comes; the influence of different determinants over time
and throughout the life cycle. While specific investigations
into a single determinant, outcome measure, or policy
intervention are relevant and may even be critical in some
cases, they must be recognized as being only part of a
more complex picture [10].
In accordance with the new definition of health [9], a
disease is a non-balanced perturbation of one or morebody function(s), including responses to infectious and
non-infectious agents [11]. Disease can affect individual
hosts by reducing growth rates or fecundity, increasing
metabolic requirements, or changing patterns of behav-
ior. It may ultimately cause death [12].
While many organisms have the potential to cause dis-
ease, infections usually have little detrimental effect on
the host. Disease occurs if the delicate balance between
hosts and parasites is upset, for example when the para-
sites become too numerous or when the immunological
capability of the host is impaired [12,13]. Infection may
also have sublethal effects that indirectly enhance mor-
tality rates by for example, increasing the susceptibility
of the infected host to predation [12].
A pathogen is usually defined as a microorganism that
causes, or can cause, disease in a host [14]. Virulence
and pathogenicity both refer to the ability of a pathogen
to cause disease. However, while virulence is a continu-
ous variable defined by the amount of damage that is
caused, pathogenicity refers to the quality of disease in-
duction and is a discontinuous variable (yes or no) refer-
ring to the capacity of a microbe to cause damage in a
(susceptible) host [14]. It is not possible to draw a clear
and unequivocal distinction between pathogens and
non-pathogens. Properties conferring pathogenicity de-
pend as much on the host as they do on the micro-
organism. They may be influenced by multiple factors
such as environmental stress, pollutants and other mi-
croorganisms [15-17]. Such alterations can create condi-
tions in which the host becomes vulnerable to microbes
which were previously non-pathogenic. When the im-
mune response of the host to a microbe is insufficient,
microbial factors can cause damage; when microbial fac-
tors fail to stimulate the immune system, the microbe
can disseminate and cause disease; and when the im-
mune response to a microbe is too exuberant, it can be
the immune response itself that is responsible for the
pathology. In other words, pathogenicity can be due to
the immune response to the pathogen rather than to the
pathogen itself [14]. Consequently, attempts to classify
micro- or macroparasites as pathogens, non-pathogens,
opportunists, commensals and so forth are misguided
because they attribute a property to the parasite that is
instead a function of the host, the parasite and their
interaction [14].
Wildlife health investigations: data sources and factors to
consider
Health surveillance: objectives and methodology
The World Organisation for Animal Health (Office
International des Epizooties, OIE) defines surveillance
(or epidemio-surveillance) as the on-going recording of
diseases in animal populations with a view to disease
management [5]. In short, surveillance means “information
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making, including policy and priority setting, response to
outbreaks and approval of trade movements. The outputs
generated by wildlife surveillance systems can include the
detection of new disease events, the demonstration of
freedom from specific diseases or infections, or identifica-
tion of the level and distribution of diseases endemically
present in a population [18,19]. The first integral activities
of disease surveillance are detection of disease or patho-
gens. Further activities include information management,
i.e. analysis of the collected data and use of the surveil-
lance information for decision-making and policy formu-
lation [20]. For these two last aspects, it is essential to
record and store data, e.g., to continuously conduct a
database and to communicate important results such as
disease emergence to the competent managers and au-
thorities. Indeed, a key aspect of health surveillance is the
early detection of outbreaks or what we call early warning
systems.
Scanning surveillance (also called general or passive
surveillance) refers to the recording of cases as they
occur and are submitted for investigation. It usually cor-
responds to clinical surveillance aimed at detecting dead
or visibly sick animals (followed by diagnosis or precise
disease identification), i.e., identifying disease events in
which wild animals are the victims [4,20]. Scanning sur-
veillance is typically performed by investigation of animal
carcasses or tissues from dead animals. The accurate iden-
tification of a mortality event requires a thorough patho-
logical examination carried out by a wildlife specialist
following standardized procedures and complemented by
further laboratory analyses [5]. However, in the case of im-
portant pathogens such as zoonotic agents or those with
economic importance for which wildlife hosts may act as
healthy carriers, surveillance cannot be based on the col-
lection of clinical data such as morbidity or mortality [5].
Targeted surveillance (formerly called active surveil-
lance) is carried out when dead or living animals are
proactively sampled specifically for the purpose of inves-
tigating them to detect a selected disease or pathogen,
whether or not the infected or exposed wild animals are
sick [5]. These investigations may focus on populations
of apparently healthy animals [4,20]. Traditionally,
targeted surveillance of wildlife has relied on a cross-
sectional study design because this only requires a point
sample (single capture or sample collection). Collected
data most often relate to the identification of risk factors
associated with disease, pathogen, or antibody preva-
lence. It is therefore essential to aim at a sample size
that can provide reliable prevalence estimates and statis-
tical comparison and to incorporate relevant biological,
spatial and temporal variables [21].
Although collection and sampling of animal carcasses
represent a major data source for wildlife health surveil-lance, there are a number of alternative methods for
accessing health information. Data from slaughtered
farmed wildlife such as deer of from domestic animals
potentially exposed to wildlife pathogens provide evidence
of pathology as well as samples of blood and parasites
[18,22-24]. Appropriate diagnostics (such as standardized
health screening, ancillary diagnostic tests and thorough
postmortem examinations) on diseased wild animals sub-
mitted to wildlife rehabilitation centers can enhance sur-
veillance efforts [21,25-27]. Clinical examinations can be
performed within the context of wildlife captures [28,29]
and are an essential component of translocation programs
due to the substantial health risks involved [30]. Photo-
trapping can deliver valuable information about diseases
with typical external lesions such as sarcoptic mange [31]
(Figure 1). Infrared thermal imaging has been tested as a
potential tool for the tele-diagnosis of sarcoptic mange in
the Spanish ibex (Capra pyrenaica) [32]. Non-invasive
samples, such as feces, hair and feathers may be suitable
for the detection of pathogens or toxic compounds. For
example, in a study on endoparasites in Alpine ibex
(Capra ibex ibex), the number of feces samples collected
from captured animals was insufficient for a comprehen-
sive study and was substantially increased by collecting
feces from the ground [29]. Finally, questionnaire surveys
and interviews with wildlife managers, hunters and others
working in the field can provide valuable information on
disease occurrence.
Participatory approaches to surveillance have indeed
been recently proposed as an interesting complement to
more structured and quantitative methods [19]. It is an
important principle of participatory epidemiology that
stakeholders such as animal owners (or, in the case of
wildlife, hunters or game-wardens) have valuable tech-
nical knowledge essential to understanding epidemio-
logical scenarios. Obtained data can be validated by
triangulation when information from diverse sources is
collected. This method has been successfully applied to
the surveillance of sarcoptic mange, a disease character-
ized by typical macroscopic skin lesions [33,34], and to
document an epidemic of an alopecic syndrome associated
with deer ked (Lipoptena cervi) infestation in Norwegian
moose (Alces alces) [35]. Participatory approaches and tri-
angulation have also been used to record interspecific inter-
actions that may enable pathogen transmission [24,36,37].
Cutler and collaborators suggested that syndromic ap-
proaches might be a better way of disease detection than
searching for specific pathogens [38]. Syndromic surveil-
lance is meant as an early warning system aimed at iden-
tifying case clusters before diagnoses can be confirmed
and reported to the relevant health agencies, in order to
mobilize a rapid response [39]. A syndrome is a collec-
tion of frequently associated clinical signs putatively
linked to a given etiology or to given risk factors.
Figure 1 Detection of diseased animals by camera traps set by hunters and game-wardens. A. Marked enlargement of the lower jaw in a
roe deer (Picture: Martin Wyler). B. First detection of sarcoptic mange in a wild boar in Switzerland (Picture: Alex Hofer). Notice the extended alopecia
on the ventral parts of the body. C. Eurasian lynx affected by sarcoptic mange (Picture: Pierre Jordan). The emaciation and shaggy fur are obvious. This
animal was subsequently captured, marked and treated. D. Same lynx as on picture C, six months after treatment (Picture: Pierre Jordan).
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Thus, syndromic surveillance uses the clinical, patho-
logical or epidemiologic characteristics of disease occur-
rences to assess whether these are linked, instead of
relying on the detection of etiologic agents or well-defined
disease pictures. The number of cases with defined syn-
dromes can be tracked in space or time [4,5]. Macroscopic
findings were indeed shown to be valuable for identifying
distinct pathological profiles among collected wild animal
carcasses. Besides the potential usefulness for early out-
break detection, this classification system represents a tool
for retrospective investigations [40]. In a study on roe deer
(Capreolus capreolus capreolus) mortality in Switzerland,
classifying data according to syndromes has proven useful
for describing morbidity and morbidity causes, including
analyses of cases of unclear etiology [41].
Risk assessment should guide surveillance [42], in par-
ticular targeted surveillance (long-term data collection)
or surveys (“snapshot” information). Risk-based investi-
gations focus on areas where the probability of occur-
rence or the seriousness of the consequence for the
target population is expected to be highest [5] and pro-
vide cost-effective, early detection of disease introduc-
tions or emerging health problems [19,21]. For example,
targeted investigations on bovine tuberculosis in Swiss
wildlife focused on areas along the border of the coun-
try, based on the knowledge that Switzerland is officiallyfree of tuberculosis while the number of cases in wildlife
has been increasing in all neighboring countries [43].
Adaptive surveillance corresponds to a cost-efficient,
situation-based strategy for the surveillance of conta-
gious diseases associated with noticeable morbidity or
mortality in wildlife [44]. Investigations into the efficacy
of using different information sources for detecting dis-
ease occurrence showed that analysis of indicator ani-
mals (i.e., animals found dead or presenting disease
signs) is more efficient than analysis of animals expected
to be healthy (such as hunted animals). This observation
led to the recommendation of focusing surveillance ef-
forts on indicator animals when a disease of concern ap-
pears to be absent in a wildlife population. Enhanced
surveillance efforts, including systematic sampling of
apparently healthy animals for prevalence estimation,
should only be implemented when cases have been de-
tected. Towards the end of an outbreak, the aim of dis-
ease surveillance should shift back to case detection
[44]. This approach has been applied for rabies in
Switzerland, where surveillance efforts progressively
evolved towards clinical surveillance after rabies was
eradicated [45].
Sample selection and diagnostic tools
Method selection for wildlife health surveillance should
ensure repeatability and data quality. It is important to
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antibody). Selection will depend on factors such as the
host species, expected sample size, logistic constraints,
cost of laboratory analyses and specificity and sensitivity
of diagnostic tests [46]. A pathological examination is re-
quired to determine the cause of death or disease of an
animal. This examination identifies tissue lesions and
paves the way for appropriate additional investigations,
such as bacteriological or parasitological examination.
Also, the presence of lesions must be demonstrably asso-
ciated with a given pathogen to prove that an etiological
link exists between pathogen and death. Detection of ex-
posure to pathogens is generally achieved by laboratory
analyses such as agent isolation, PCR testing or serology
[5]. To spare costs, it may be advisable to pool samples
for analysis [37,46,47]. Non-infectious diseases may re-
quire toxicologic or genetic investigations. Toxicology is
a discipline of major importance in wildlife, as both
intentional poisoning and accidental intoxications fre-
quently occur [48]. Illegal killing of wildlife is a wide-
spread problem worldwide, and forensic approaches
may be necessary when determining the cause of death
in wild animals.
Molecular epidemiology
More studies should be performed on the pathogen
strains circulating among wild animals and to compare
them to strains of domestic livestock and humans. In
many cases, researchers ignore whether or not strains
circulating among domestic and wild populations are
similar. As a consequence, epidemiological cycles of in-
fectious diseases are not well assessed in any of the pop-
ulations of concern [11]. In the case of infectious
keratoconjunctivitis caused by Mycoplasma conjunc-
tivae in Alpine ruminants, molecular studies revealed
the simultaneous occurrence of the same strain of M.
conjunctivae in different hosts of the same region, sup-
porting the hypothesis of interspecific transmission
[49]. Strains of M. conjunctivae identical to each other
were also identified both in healthy and diseased hosts,
suggesting that factors other than the strain of myco-
plasma determine the outcome of an infection [50,51].
In contrast, comparison of Brucella suis from wild boar
(Sus scrofa) and domestic pigs from the same geograph-
ical area presented differences that did not support the
assumption that wild boar were the source of the out-
break in pigs [24,52].
Historic information and baseline data
Data and samples must be stored in a way that enables
subsequent use for retrospective epidemiological ana-
lyses [4]. Baseline data and sample archives are needed:
to establish the distribution of pathogens and appreciate
their effects and epidemiology [53]; to assess perturbationover time and to understand the impact of climate and en-
vironmental change on complex systems of hosts and
pathogens [42,53,54]; for early detection and implementa-
tion of control measures [55]; to determine whether or
not the emerging character of a disease is due to the intro-
duction of infected animals (pathogen pollution) [56]; and
to assess the existence of a causal association between
pathogen and disease [29]. For example, a survey on ar-
chived samples revealed that Batrachochytrium dendroba-
tidis, the causing agent of chytridiomycosis in amphibians,
is more widely distributed in Europe than previously
thought. This result was surprising considering that die-
offs have only been infrequently reported from Europe
[57]. As laboratory tools are continuously being devel-
oped, the access to archived material opens doors for new
discoveries and allows us to learn from the past.
Besides the use of sample archives for retrospective
studies, it may be necessary to accumulate samples gath-
ered during several years until a required sample size is
achieved [46]. This is especially true when access to
samples is limited, as is the case in small and strictly
protected animal populations. Thus, a study on Trichi-
nella in Swiss carnivores included 1289 hunted red foxes
(Vulpes vulpes) sampled within less than two years,
while data from 55 Eurasian lynx (Lynx lynx) originated
from necropsy samples taken over nine years [58].
Identification of risk factors
The identification of risk factors is an important goal of
wildlife health research and surveillance [21]. Wildlife
diseases may be indirectly managed by modifying popu-
lation risk factors that enable the persistence of infection
[59]. In the case of emerging infectious diseases, know-
ledge of risk factors is considered to be particularly import-
ant, as such data represent a tool for targeted surveillance
and prevention such as improving decisions on land-use
policies [46]. The same disease at the interface of the same
two species may behave differently in different areas or sit-
uations, due to different climatic environments; different
management of one or both species; shared food, water
and mineral resources; population densities; predation var-
iables; concurrent diseases, and so forth [21,60]. Therefore,
sampling stratification is essential [46], and similar studies
should be carried out in different regions with well charac-
terized disease patterns. This will allow comparisons to
identify risk factors for disease occurrence [42].
Prevalence of infection and disease susceptibility may
vary among sexes and age classes. Just to give a few exam-
ples: endoparasite infestation is more frequent in male
than in female Alpine ibex [29]; prevalence of antibodies
to Toxoplasma gondii increases with age in Eurasian lynx
[61]; and age- and sex-related variations have been noted
in the epidemiology of Chronic Wasting Disease in mule
deer (Odocoileus hemionus) [62].
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genic effects in different host species. First, some agents
are truly species-specific. Second, susceptibility may vary
among susceptible hosts. For example, only mammals are
susceptible to rabies. Among carnivore species, canids,
mephitids, procyonids and viverids are highly susceptible,
while felids and mustelids show a lower susceptibility or
receptivity [63]. Similarly, M. conjunctivae generally cau-
ses more severe disease in Alpine chamois (Rupicapra
rupicapra rupicapra) than in Alpine ibex, and different
strains of M. conjunctivae may or may not cause disease
in either species [49-51]. Furthermore, species-specific so-
cial behavior influences the frequency and intensity of in-
traspecific contacts and consequently the transmission
rate of infectious agents, the case incidence and disease
spread among a host population [13,60]. The probability
of contacts and risk of epidemic spread is therefore higher
for social or gregarious animals than for solitary species.
For example, while sarcoptic mange and distemper rapidly
spread among red fox populations, cases in more solitary
species like the Eurasian lynx remain isolated [28,64]. Gre-
garious lifestyle and inter-group movements have been
shown to contribute to tuberculosis maintenance in some
species despite low overall prevalence in the population
[43]. Disease spread may also vary among sexes depending
on the social organization of the species. In an epidemic
of infectious keratoconjunctivitis in Alpine chamois in the
Swiss Alps, numerous females and juveniles died while
solitary adult males remained largely unaffected; after the
mating season, the number of affected males dramatically
increased [65]. Finally, interspecific interactions need to
be considered when assessing the epidemiological role of
a host species. Among other things, it is necessary to as-
sess the real status of livestock to determine the epidemio-
logical role of a wild species in domestic animal disease
[11,46]. For example, investigations on bluetongue, bovine
viral diarrhea virus and other abortive agents in wild rumi-
nants from Switzerland suggest that wildlife is not a reser-
voir but rather an occasional spillover host for these
pathogens, as infections of wild ruminants is only sporadic
while domestic ruminants display significantly higher
prevalences of infection [37,47,66]. Interspecific interac-
tions can also influence disease dynamics in other ways.
Thus, marked advances of the epidemic front of sarcoptic
mange in Sweden were associated with new vole cycles,
possibly because years with high vole numbers (i.e., high
prey numbers for foxes) result in high reproduction and
juvenile fox survival rates and thus in enhanced fox dis-
persal [67].
The possibility of temporal and spatial variation always
needs to be considered in both study design and data in-
terpretation [21,68]. Time is a quantitative scale against
which all other aspects of disease can and should be
measured [69]. The season of sampling should beconsidered whenever assessing the risk of infection by
pathogens [70] or using wildlife as an accumulative bio-
indicator of environmental pollution [11]. Pathogen
transmission is affected by climatic conditions (survival
of the pathogen in the environment, activity of arthro-
pod vectors, geographical distribution of host species)
[18] as well as by intraspecific contacts (e.g., mating sea-
son) [65] and interspecific interactions (e.g., presence of
livestock on alpine pastures during the summer grazing
season) [49,71]. Severe weather events can affect host
immunity and nutrition if they interrupt forage availabil-
ity and feeding patterns [18,70], as well as the abundance
of arthropod vectors [13]. Seasonal changes in hormonal
activities may also influence host susceptibility [72]. Be-
cause seasonal changes can be related either to climatic
conditions or to physiological and behavioral patterns, it
has been proposed that seasons be specified both as cal-
endar seasons and as species-specific biologic periods
[51,73]. An example of climate-related seasonal disease
pattern is the observed increased prevalence of sarcoptic
mange in Iberian ibex (Capra pyrenaica) in the Sierra
Nevada in winter and spring months, probably because
low temperature and high relative humidity are favorable
to mange mites [74].
Migratory behavior can strongly influence the transmis-
sion and prevalence of pathogens in a given species and
geographical area [21]. Migratory behavior is strongly
linked to seasonal changes and typically allows for con-
tacts with other hosts and thus for pathogen spread and
acquisition. For example, vertical short-distance migration
in red deer (Cervus elaphus elaphus) in the Swiss Alps
and food shortage in winter enhances the risk of contacts
between red deer and cattle during the cold season. When
red deer move to lower altitudes and share food resources
with domestic livestock, a situation known as a risk factor
for pathogen transmission arises [37]. Prevalence of low
pathogenic avian influenza virus in ducks in the northern
hemisphere is highest during late summer and early fall
(pre-migration staging) and declines during winter [68].
More importantly, horizontal long-distance bird migration
has most likely played a major role in the spread of highly
pathogenic H5N1 avian influenza in Europe [75]. Finally,
biological dispersal (animal movement away from an exist-
ing population or from the parent organisms) is known to
contribute to pathogen spread. For example, red fox dis-
persal is believed to favor the propagation of sarcoptic
mange [67].
The study of spatial distribution is especially important
when the targeted disease or infection is highly clustered
[21]. Spatial epidemiology also enables to investigate re-
lationships between the environment and the presence
of disease, and to predict disease spread [76]. Natural
barriers such as rivers and mountain ranges can tempor-
arily block disease spread, as has been observed for
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rabies in red fox in Switzerland [65,77]. Spatial represen-
tation of pathogen exposure in different species can also
contribute to the understanding of epidemiological roles.
Thus, investigations in Switzerland suggest that infec-
tions of wild ruminants with bluetongue virus are associ-
ated with foci of infection in domestic ruminants [47].
Similarly, exposure of wild ruminants to the viral bovine
diarrhea virus seems to be related to their presence on
summer Alpine pastures where interactions with cattle
regularly occur [37]. Differences in human population
density have been shown to be associated with signifi-
cantly different exposure to Toxoplasma gondii and
Orthopoxvirus in Swedish Eurasian lynx. This could
relate to the concomitant presence of domestic cats in
the area [61,73].
Differences in food availability among geographical
areas can be expected to influence host density and thus
the pattern of pathogen spread. For example, sarcoptic
mange has had a stronger impact on red fox populations
in boreal forests than in mixed agriculture-forest areas
of Sweden. This is presumably because groups of foxes
are larger and live in smaller territories in highly pro-
ductive regions, and because the more patchy distri-
bution of food and shelters favor disease spread [78].
Environmental characteristics such as temperature and
humidity can impact pathogen survival. Thus, foxes are
more often infected with Echinococcus multilocularis in
humid than dry environments [79]. Pathogen and dis-
ease distribution can also vary with altitude (due to
variations in the distribution of susceptible hosts and
in the occurrence of arthropod vectors) and with sun
exposure (influencing climatic conditions and thus
pathogen persistence in the environment) [18]. The re-
sults of recent investigations on infectious keratocon-
junctivitis in wild Caprinae have suggested a role of
altitude (or associated environmental conditions such
as UV-light, temperature, humidity) in pathogenesis of
eye lesions due to Mycoplasma conjunctivae [80]. Also,
soil composition, vegetation and stagnating water can
influence the occurrence of pathogens and their vec-
tors or the presence of toxic compounds [18]. Overall,
natural and anthropogenic barriers and spatial distribu-
tion of wild and domestic hosts need to be taken into
consideration when defining epidemiological or sam-
pling units [37,50,66,81].
Recording disease-related information in a format
compatible with the Geographic Information Systems
(GIS) enables analyses on the potential influence of fac-
tors such as climate, forest type, stream location, relief
and human demography on disease and pathogen occur-
rence [18]. The system can, for example, easily derive
the altitude of sampling locations from the geographical
coordinates [47,80].Research, experiments and modeling
Descriptive epidemiology deals with the occurrence and
extent of a disease as well as the frequency and distribu-
tion of risk factors in populations (what, who, where and
when; e.g., [65,82,83]). However, analytical and experi-
mental approaches are also needed to study causal rela-
tionships (how and why). Controlled experiments allow
for a better understanding of pathogenesis, contribute to
the development and validation of diagnostic methods
and to targeted management recommendations [21,56].
Experimental studies should ideally combine lab experi-
ments (e.g., experimental infections) with field experi-
ments (e.g., testing hypotheses regarding the effect of
host aggregation and density on disease prevalence or
pathogen persistence). Furthermore, mathematical mod-
eling may help to identify knowledge gaps and design
experimental research [56]. Models can also contribute
to the understanding of disease dynamics and the impact
of diseases on populations [84,85]. However, it is import-
ant to remain cautious in basing models on extrapola-
tions of information about other species, as this can lead
to erroneous conclusions [86].
Method harmonization
Coordination between wildlife monitoring programs and
standardization of both diagnostic protocols and proto-
cols for estimation of population abundance among the
different regions and countries are needed. Such coord-
ination will allow a global and harmonized evaluation of
disease status and associated risk factors [11,56]. As an
example, a recent attempt to compare worldwide preva-
lences of bovine tuberculosis and host population dens-
ities (considered as an important risk factor for disease
maintenance) revealed that such a comparison is nearly
impossible due to the diversity of diagnostic and count-
ing methods applied in the various geographical areas
[43]. Important steps towards the harmonization of
methods have recently been initiated. Examples are the
publication of the Training Manual on Wildlife Diseases
and Surveillance by the OIE [87], the publication of
Diagnosis Cards by the EWDA (www.ewda.org) and
the initiation of international research projects such as
WildTech (www.wildtechproject.com) and APHAEA
(www.aphaea.eu).
Multidisciplinary approaches
There is a need to adopt a multidisciplinary and integra-
tive approach in investigations on wildlife health, includ-
ing both research and surveillance [1,53]. Early warning
and response systems for emerging zoonoses require effect-
ive cross-jurisdictional and interdisciplinary collaboration
[21]. Also, the integration of perspectives and expertise
from diverse branches of the natural and health sciences
such as ecology, zoology, veterinary medicine, human
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the social sciences, into studies of emerging human and
domestic animal disease is essential to understanding
the role of environmental changes in disease emergence
[1,42]. Veterinarians and other health professionals must
become integral parts of the teams dealing with wildlife
management and research [88]. In the frame of field pro-
jects, veterinarians ought to participate fully in project
planning and realization and should not only become in-
volved when emergencies occur such as injured animals
or critical wildlife immobilization events [30,59]. Similarly,
veterinarians must collaborate with experts in other disci-
plines when addressing questions related to wildlife health.
In particular, cooperation with field ecologists and wildlife
managers with a good knowledge of the local host popula-
tions is invaluable.
Human dimension: communication and politics
As the importance of wildlife health is increasingly rec-
ognized, the need for high standards is more and more
emphasized by the scientific community. In contrast, the
human dimension of wildlife investigations is rarely ad-
dressed. This is rather surprising as the collaboration
with field professionals, local managers and the general
public, is usually essential to accessing information on
wildlife health. Nevertheless, there has been a recent rec-
ommendation for taking the country’s historical and cul-
tural context into account in the frame of wildlife
sampling [4]. The increasing interest in participatory
epidemiology also underlines the need for a customer-
oriented approach. Pro-active work in the field and the
delivery of surveillance outputs that are meaningful to
stakeholders are required, because motivation to carry
out effective disease surveillance will decrease in the ab-
sence of adequate feedback [19]. Participatory ap-
proaches, translated into the field of wildlife disease
investigation, mean improved communication between
hunters or wildlife managers and animal health services.
Presence of researchers in the field (e.g. participation in
sample collection, courses) combined with providing
regular feedback to field partners positively influences
the access to general information on disease occurrence
and facilitates sample collection [89].
It is essential to pay careful attention to the knowledge
transfer and academic-practice partnerships [10]. Active
education campaigns must be based on current science
and avoid reacting defensively to rumor and misinforma-
tion [86]. The public must come to understand that the
disruption of complex relationships within the ecosys-
tem may have disastrous unforeseen consequences for
human health. Patz and collaborators have gone so far
as to recommend selecting research questions collabora-
tively with the local community and decision makers
and fully integrating research findings into the social,economic and political dialogue, both globally and lo-
cally [42]. What this boils down to is quite simple: ad-
equately informing the public in order to generate
political will for effective change.
Finally, as free-ranging wildlife does not respect political
borders, interregional and international communication is
essential for early disease detection and timely implemen-
tation of preventive measures. For example, classical swine
fever has emerged in southern Switzerland due to move-
ments of free-ranging wild boar coming from Italy [90],
and the spread of H5N1 avian influenza in Europe has
been largely due to migratory flows of wild birds [75].
Overall, networking is a key factor in building and sustain-
ing surveillance and response capacity against existing and
emerging diseases [21].Training and education
It is critical to build up specialized programs and to
avoid the temptation to simply transfer the methodology
usually applied to domestic animals to wildlife [59].
There is currently an obvious need for professional edu-
cation in wildlife health both at the undergraduate and
postgraduate level [56,59,88]. However, while curricula
of veterinary students, at least in Europe, continue to de-
vote only a small number of hours to wildlife diseases,
an increasing number of postgraduate education pro-
grams are being offered in wild and zoo animal medicine
[91]. Most recently, the European College of Zoological
Medicine (ECZM) has developed the specialty “Wildlife
Population Health” and is currently setting up the corre-
sponding residency program (www.eczm.eu).
Since there is only a limited number of appropriately
trained veterinarians and positions available, it is essential
that those actively involved in these fields train and impart
knowledge to non-veterinarians [88]. There is a general
need to initiate regional training for capacity building to
improve disease surveillance in wildlife [70]. Among
others, many biologists are not familiar with wildlife path-
ogens and health disorders [4]. To contribute to filling
these gaps, the OIE has published manuals such as “Quar-
antine and Health Screening Protocols for Wildlife prior
to Translocation and Release into the Wild” [92], “Post-
mortem Procedures for Wildlife Veterinarians and Field
Biologists” [93] and the more recent “Training Manual on
Wildlife Diseases and Surveillance” [87].Sharing existing information
In earlier times, knowledge acquired from wildlife health
surveillance was published – at most – in the local lan-
guage in local journals. Publication of scientific articles in
international revues is now increasingly recognized as a
necessary means of communication for the worldwide ex-
change of information, and the possibilities for distributing
Figure 2 Yearly numbers of bird carcasses submitted to the
Centre for Fish and Wildlife Health, Switzerland. The peak of
submissions in 2006–2007 was associated with the avian influenza
outbreak in Switzerland [101] and the recrudescence of cases in 2010
was partly due to an epidemic of salmonellosis in passerine birds [99].
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easier and cheaper.
Scientific institutions increasingly require scientists to
fulfill expectations regarding the quantity of published
articles and the mean impact factor of the selected jour-
nals. Funding attributed for future research may even
depend on these factors. While this pressure encourages
researchers to publish their data, it may discourage them
from reporting information arising from small sample
sizes, which is considered less valuable than results from
more elaborate, larger studies. However, the difficulties
inherent in wildlife health investigations (see below), the
need for baseline data, the complete lack of reports in
certain regions of the world or on secretive species, may
render anecdotal information or negative results valuable
for surveillance purposes. Also, it is important to keep in
mind that publication is a means of communication for
sharing experience and information, and not primarily a
vehicle for prestige and recognition. Negative data are
greatly underrepresented in the literature despite the fact
that they can be extremely important to our understand-
ing of diseases [21]. Among others, the absence of pa-
thogen exposure detection provides necessary baseline
data in the surveillance of emerging diseases. Similarly,
the value of publishing failed experiments is underesti-
mated. It is important that we benefit from each other
mistakes and not continue to reinvent the wheel [94].
Difficulties inherent to health investigations in wild
populations
Surveillance and research on wildlife-related diseases are
associated with a number of challenges which include
not only the practicality of the case, sample and field
data collection, but also the interpretation of field data
and the validation of field observations through experi-
mental studies [21]. A further difficulty associated with
wildlife is its wide taxonomic diversity [4]. This requires
knowledge of zoology (species identification) and of
species-specific issues such as anatomy, pathology, dis-
ease susceptibility and ecology.
Access to investigation material
Wildlife case submissions are dependent on a complex
of interrelated natural and decision-making outcomes
[21]. Scanning surveillance requires the observation of
clinically diseased or dead animals, reporting these ob-
servations, and the submission of carcasses or samples
by the public and field professionals for analysis. Overall,
only a very small portion of dead wildlife is both found
and examined. Wild animals may inhabit remote areas
and are often difficult to approach and examine; clinical
expression may be brief [5] and survival behaviors often
mask clinical signs of disease in wildlife [86]; capture and
containment of moribund animals may not be feasible andrepresents additional steps to be surmounted in the sub-
mission chain [21]. Predation, scavenging and carcass de-
composition may obscure the observation of dead animals
and usually complicate the diagnostic process when car-
casses are found [21,86]. Detection biases can arise from
the cause of death. For example, a study on Eurasian lynx
showed that infectious diseases are underrepresented in
animals found by chance while mortality resulting from
anthropogenic activities is overrepresented [95]. The use
of dogs has been shown to be an efficient method for in-
creasing detection of diseased or dead animals, including
medium-sized to small mammals particularly difficult to
detect, and thus of decreasing bias in the recovered study
material [96,97].
Reporting efforts are strongly associated with personal
interests, education and contacts with competent labora-
tories [69]. The perceived value of individual species (e.g.,
game vs. non-game) or perceived need for a submission
(mass mortality vs. single case, awareness of pathogen
spread) will largely influence the decision of whether or
not to submit a carcass for pathological investigation [21].
Thus, after the first cases of H5N1 highly pathogenic avian
influenza were discovered in Switzerland in 2006, a signifi-
cant rise of bird carcass submission was noticed at the
Centre for Fish and Wildlife Health (FIWI) in Bern al-
though all potential influenza cases were sent to the refer-
ence laboratory at Zurich University (Figure 2). Similarly,
the number of submitted red foxes and Eurasian badgers
(Meles meles) dramatically increased during an epidemic
of distemper in wild carnivores [64], including cases that
had died of other diseases (FIWI archives, unpublished
data). However, despite the listed impediments, scanning
surveillance retains considerable potential value. It pro-
vides an ideal setting for disease discovery, in particular of
emerging diseases of wildlife, as has been the case for
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United States [21], for babesiosis in Alpine chamois and
salmonellosis in passerine birds in Switzerland [98,99] or
for avian pox in British tit species [100].
Targeted surveillance and research in wildlife require
proactive sample collection. To guarantee a certain level
of detection and accuracy, the number of samples needed
is a function of the population size combined with the ex-
pected number of positive animals. When an expected
prevalence is not known, sampling intensity should focus
on finding at least one positive animal assuming a very
low prevalence, which often requires a very large sample
size [68]. This approach has been successfully used in
studies on bluetongue virus and bovine viral diarrhea virus
infections in wild ruminants in Switzerland [37,47]. Ideal-
ly, samples originate from sources that do not comp-
romise animal health. However, capture options are often
limited. Wildlife trapping requires a considerable know-
how, is extremely demanding in both time and financial
resources and may result in very low sample sizes [21,94].
For example, in Switzerland in the winter of 2011/2012,
six months of “capture duty” with three different capture
systems [102] and the contributions of numerous biolo-
gists, veterinarians, hunters and professional game war-
dens, resulted in the capture of four Eurasian lynx.
Similarly, three capture seasons of 2–3 months each in-
volving full-time presence of a capture team in the fields
on a single study site resulted in samples from 39 ibex
[29], while blood samples from 520 hunted ibex were
obtained during the corresponding hunting seasons
[66]. Additionally, legal constraints may prevent system-
atic sampling of a wild animal population [94].
Sample collection during hunting season generally en-
sures access to a large amount of samples but it depends
on hunters’ compliance and hunting success. This method
is also limited to specific periods of the year and geo-
graphical areas. Hunted animals are often selected based
on nonrandom criteria such as antler development or on
hunting plans and may not be representative of either the
age or gender structure of the population. In addition,
capture or killing of animals for specimen collection may
result in the rapid dispersal of contagious animals [86].
Consequently, plans for general surveillance are often lim-
ited to opportunistic sampling of animals using whatever
means are available to collect specimens for necropsy and
laboratory tests [4]. Even in the frame of targeted investi-
gations, sampling largely results in convenience sampling
despite strong efforts towards representativity and stratifi-
cation. Overall, sample collection of free ranging wildlife
usually represents a compromise due to availability [21].
Sampling materials should be selected based on how
easy they are to collect, transport and ship and on re-
frigeration requirements, due to sampling conditions in
the field and due to the necessary involvement of non-veterinarians in most sampling campaigns. In the case of
large sample sizes, sample volume and shipment costs
also need to be considered [103-105]. Depending on the
objectives of the study, samples such as swabs or body
fluids may represent a suitable alternative to tissue col-
lection and significantly increase hunters’ compliance.
Filter papers seem to be a promising tool for antibody
surveys, as they are an inexpensive sample media well
suited for harsh environmental conditions [103]. Simi-
larly, FTA technology (fast technology for analysis of nu-
cleic acids, i.e., a paper-based system designed to fix and
store nucleic acids directly from fresh tissues) represents
an alternative method when field conditions limit the
ability to properly store or ship traditional sample mate-
rials. Among others, the cards can inactivate infectious
agents, which reduces the risk and restrictions associated
with transporting samples [105]. When samples like blood
or body fluids are not obtainable from carcasses, the use
of fluids obtained from organ samples such as lung extract
[106] or meat juice [107] may be considered.
Diagnostic limitations
Tissue and fluid degradation in carcasses that have
remained in the environment for an extended period of
time poses serious diagnostic problems. Autolysis greatly
limits the interpretation of gross necropsy and histologic
findings. Degradation also influences sensitivity of diag-
nostic tests. Furthermore, the use of often highly con-
taminated bloody fluids collected from carcasses may
result in noninterpretable or unreliable test results.
However, studies on red foxes and wild boar have dem-
onstrated that hemolytic body fluids are suitable for ser-
osurveys. Hemolysis may result in a loss of sensitivity,
however it seems that storage time and temperature as
well as thawing-freezing cycles influence the results
more than hemolysis itself [47,106,108,109].
Optimum tissues or samples for pathogen detection
may vary between species or between systems [21]. For
example, nasal swabs have proved effective for detection
of Aujeszky disease virus in domestic pigs but not in
feral pigs [110]. Differences in viral loads among differ-
ent hosts, the occurrence of cross-reacting antigens and
sequence similarities among closely-related pathogens
can also significantly affect the reliability of diagnostic
test results. It is therefore strongly recommended to val-
idate serological tests with experimental trials and, in
the case of PCR-based diagnostics, to carry out amplicon
identification through sequencing [21].
There is a need to develop diagnostic tests appropriate
for wildlife species. Many tests designed for domestic
mammal samples do not have the same levels of sensi-
tivity and specificity when used in wild species [5,56].
Whereas tests aimed at directly detecting the pathogen
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imals, indirect tests such as ELISA – which are based on
detecting the immune response of the host to the patho-
gen and thus depend on the recognition of specific pro-
teins associated with that response – may not deliver
reliable results [5]. Validation of diagnostic tests in wild-
life is associated with a number of challenges such as the
difficulty to obtain enough positive and negative con-
trols, the lack of gold standards, the large number of ani-
mal species and limited financial resources. Nevertheless,
efforts made to overcome these problems are increasing.
For example: the EWDA Wildlife Health Surveillance
Network has initiated the edition of Diagnosis Cards
recommending diagnostic techniques appropriate for
wildlife testing (www.ewda.org); the WildTech Project
aims at developing new technologies for the improve-
ment of wildlife health surveillance (www.wildtechproject.
com); and the APHAEA project will propose harmo-
nized methods for diagnostic investigations in wildlife
(www.aphaea.eu).
New diagnostic tools may also contribute to overcom-
ing difficulties related to sampling conditions and the
limitations of traditional diagnostic tests. Loop-mediated
isothermal amplification (LAMP) and RT-LAMP have
several advantages over PCR and RT-PCR. They can be
carried out at constant temperature in a single tube with
conventional instruments; the reaction requires a shorter
time; the result can be judged with the naked eye and
without opening the tubes; and specificity is higher
[111]. Genomic tools such as microarray-based analysis
of pathogens are new technologies that overcome the
technical limitations of current analytical methods (e.g.,
phylogenetic analysis, proteotyping) and are expected to
contribute to the rapid identification of newly emerging
disease agents [112].Impediments to experimental studies
Experiments in wildlife are associated with a range of
difficulties, including animal procurement, husbandry
and housing requirements, artificial infection route or
doses, costs related to extended studies and a number of
unrecognized variables such as genetics or exposure his-
tory. Furthermore, important environmental factors rele-
vant to the pathogenesis are not present and consequently
experiment results may not reflect the field situation [21].
For example, an experimental infection could only repro-
duce mild signs of infectious keratoconjunctivitis in Al-
pine ibex. It was unclear whether this was related to the
strain of M. conjunctivae selected for the experiment, or
to unknown environmental factors playing an important
role in disease pathogenesis [113]. It is therefore essential
to cross-validate and question both experimental and field
data [21].Distinguishing disease from infection
Pathogen distribution and prevalence may be larger than
disease distribution and prevalence. In a susceptible ani-
mal, exposure may lead to inapparent (or silent/subclin-
ical) infection or to clinical infection with disease signs
of variable severity and resulting in different outcomes
including chronic illness, recovery, or death. Despite the
absence of clinical signs, infected animals may shed the
pathogen either continuously or intermittently. Such a
carrier status may occur in inapparent infections (healthy
carriers), during incubation (incubatory carriers), or dur-
ing recovery (convalescent carriers) [114]. Considerable
misunderstanding has arisen from using serosurveys for
wildlife disease surveillance because the distinction be-
tween infection (past or current) and disease is not always
recognized. This leads to the misconception that infec-
tious diseases are widespread in free-ranging wild popula-
tions. When an infectious agent is endemic and the host
has evolved in this given environment, disease is the ex-
ception, not the rule [13]. For example, the hemoparasite
Cytauxzoon felis is widespread in healthy bobcats (Lynx
rufus) and only rarely associated with clinical signs, but it
generally causes fatal acute disease in domestic cats [115].Linking molecular and descriptive epidemiology
Molecular epidemiology uses methods for characterizing
DNA or protein amino acid sequences in conjunction
with epidemiologic analyses to describe the distribution
and determinants of disease in defined populations. It is
an extremely valuable tool but conclusions about the or-
igins and behavior of infectious agents denoted solely
from molecular findings can be misleading [116]. To as-
sess the epidemiological role of different hosts, it is essen-
tial to combine results from molecular analyses with field
data, prevalence and risk factor studies.Lack of basic knowledge about host species
A unique aspect and challenge to epidemiologic studies
involving wildlife relates to the need to integrate the col-
lection of both disease and basic biological data [21].
Technical difficulties often include the lack of baseline
information on the disease and the population in ques-
tion [29]. There is also a lack of basic knowledge (such
as susceptibility, carrier status, transmission potential)
concerning many diseases in wild species [86]. Import-
antly, there is often a lack of information on natural his-
tory, behavior, anatomy and physiology of wild species.
Food habits, basic nutritional requirements, home range
size, gross and microscopic appearance of normal tissues,
concentration of blood constituents, expected parasite
fauna and age at first reproduction may represent critical
data for understanding a disease. Therefore, the study of
disease in a wild species often must include a substantial
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cies [69].
Inaccurate age classification
Age is often a critical variable in epidemiologic investiga-
tions but there is a lack of defined age criteria for many
wildlife species; furthermore, even if available, these age
criteria usually allow only gross categorization such as
juvenile vs. adult, resulting in a lack of precision. The
first limitation associated with age is related to exact age
determination. Various methods have been described in
fur animals [117]. Horn growth delivers accurate infor-
mation in bovids while antler size in cervids is useless.
Tooth wear provides inaccurate data of limited reliability
in case of a sole macroscopic examination. Counting
horn cementum annuli of tooth roots allows exact deter-
mination of age in many animals and is often applied on
carnivores [73,118] but it is very expensive. This method
is less appropriate in hunted game from which trophies
are systematically collected. Furthermore, tooth extrac-
tion for the sole purpose of determining age is question-
able in live animals.
The second limitation is related to the lack of mean-
ingful and harmonized definitions of age classes. In par-
ticular when addressing questions related to disease
transmission and intra- or interspecific interactions, it is
important to consider the species-specific behavior of
the host when defining age classes [50,51,73].
Missing population data
Population data needed in an epidemiologic study may
include population size, density, age structure, sex ratio,
recruitment and losses, home range size, habitat uti-
lization, occurrence of sympatric species and migration
behavior. Such information is often critical to under-
standing pathogen transmission and maintenance within
wildlife populations [21]. Population size is also required
to determine the sample size needed for prevalence esti-
mation. Furthermore, health surveillance data have to be
combined with the monitoring of wildlife abundance
and the study of wildlife ecology to determine whether
the emerging character of a disease is due to the
introduction of infected animals (pathogen pollution)
or to a change in the population dynamics of a host or
vector [56].
Obtaining a census or even reliable estimate of the
population is problematic for many wildlife populations
[86]. Population data often are in the form of an index
rather than of a true estimate. Such indices can be used
to demonstrate trends but give no information on popu-
lation numbers, densities, or spatial distribution [21].
Consequently, the proportion of cases in a sample can
only be considered as an indication of the probability of in-
fection or exposure to the pathogen [5]. The identificationof population impacts due to disease, which represents an-
other important goal of wildlife health investigations, is
also particularly challenging [21]. Overall, there is an ur-
gent need to develop improved methods for estimating
animal abundance [5,43].
Difficulties in comparing data
In addition to the needs to harmonize methods of diag-
nostic testing, of estimating population abundance and
of age classification, further factors may impede data
analyses. The access to accurate information regarding
the origin of the sampled wild animals can be difficult,
as coordinates are not systematically submitted with
samples. Also, points of capture and sampling are not
necessarily representative of the living environment of
animals, especially in species with extended home ranges
[21,80]. This problem can be partly overcome by using
geographical units for analyses, but data on different
hosts are rarely available at the same spatial resolution
and at a high enough resolution to allow meaningful infer-
ences to be made [46]. Furthermore, there is often a lack
of data concerning species interactions as well as the in-
fection status in other species [11,37,46,66], and it is rarely
possible to follow up on individual animals [37,51,69].
When analyzing surveillance data, interpretation must
take into account the constancy and uniformity of sur-
veillance pressure [4]. Both the intensity of surveillance
efforts (related both to the program design and to the
skills and personal interests of the involved personnel)
and the method selection for surveillance (including
diagnostic methods) may vary over time and limit the
comparison of results. Furthermore, there are no long-
term records of disease prevalence or baseline estimates
of disease impacts on fitness for most wild populations
[54]. Even if old records exist, they may be only available
in paper form and difficult to understand or read; data-
base software now facilitates information storage, how-
ever, multiple changes of software over time may render
access to former digital reports impossible.
Political and financial restrictions
In addition to science-related difficulties, political and fi-
nancial difficulties play a major role in the attempt to
perform disease surveillance and management in wild-
life. Overcoming these difficulties requires great efforts
in interagency team building (biologists, animal health
specialists, public health investigators, authorities) and
involvement and education of the public [86].
Conclusions
In a fast changing world with an increasing number of
emerging diseases affecting wildlife, domestic animals and
humans, the need and interest for effective wildlife health
investigations including both surveillance and research, is
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is often mentioned as a cause of emerging diseases. In
contrast, wildlife health surveillance produces knowledge
that benefits at least three different agencies, namely ani-
mal health, public health and conservation [46]. However,
methods applicable to and knowledge acquired from stud-
ies related to domestic animal health can only partly be
extrapolated to wildlife.
In a former review, Boadella and collaborators formu-
lated six recommendations for monitoring of wildlife
diseases: to perform monitoring in relevant domestic an-
imals and/or humans in addition to investigations in
wildlife; to consider background information on wildlife
population ecology; to select the appropriate wildlife
hosts for monitoring; to select appropriate methods for
diagnosis and time/space trend analysis; to define the
target parameters for monitoring; and to establish a rea-
sonable sampling effort and suitable sampling stratifica-
tion [46]. The present review is in agreement with these
recommendations but emphasizes five further needs of
wildlife health investigations: (1) communication and col-
laboration (human dimension, networking and publica-
tion); (2) use of synergies and triangulation approaches;
(3) investments for the long term; (4) systematic collection
of metadata, i.e., information on the sampled animals such
as age, sex and geographical origin; (5) harmonization of
definitions and methods.
Participatory approaches, networking and transdisci-
plinary communication are key factors in efficient wild-
life health surveillance. First, reports of unusual health
events and the submission of carcasses largely depend
on disease awareness, personal interests and the good
will of the public and of field professionals. Second, tar-
geted studies dealing with infectious pathogens generally
require an effective collaboration with hunters, as the
carcasses of hunted animals are an irreplaceable source
of samples. In this context, direct human contacts are
essential for a sustainable surveillance system. CloseFigure 3 Challenges inherent in wildlife health investigations.interactions with field partners and regular feedback
should be an integral part of any project requiring wildlife
samples. Sharing knowledge is a bilateral process in which
all involved partners give and receive. However, as new
technologies are developed, as software systems allow bet-
ter data storage and as electronics facilitate rapid commu-
nication, the human dimension of wildlife health
investigations tends to be neglected. Along similar lines,
Nature recently quoted an epidemiologist as warning
against the “mirage of technology” in surveillance; he
emphasized that “the labs’ top priority should be build-
ing teams of local staff who are familiar with the region,
its language and practices, such local knowledge being
crucial to interpreting data” [119]. Nevertheless, when
non-professional field partners are recruited for sam-
pling campaigns, it is essential to provide them with ad-
equate equipment and information to ensure personal
safety.
Interdisciplinary collaboration is not only necessary for
a comprehensive approach to wildlife-related health issues,
it is also an enriching experience for everyone involved.
But mutual respect is crucial for effective and productive
cooperation. Open minds and curiosity for each other’s
field of expertise are essential. Also, considering the dif-
ficulties in accessing wildlife samples, the challenges en-
countered in the frame of laboratory analyses and the
value of population biology in interpreting results, the
contributions of all parties should be equally acknowl-
edged, from project planning to data publication.
Per definition, surveillance is carried out with the goal
of providing data useful for developing management
strategies. Knowledge obtained through surveillance ef-
forts should be made available not only to local services
but also to the international scientific community. The
growing number of professional networks accessible via
internet platforms and email groups provides the oppor-
tunity to exchange information rapidly and efficiently.
Also, the number of published articles in scientific
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lications are partly promoted for prestige purposes. This
attitude bears the risk of neglecting less impressive but
useful data, such as negative results, baseline values or
case reports. Furthermore, grants are generally allocated
for new data collection but not for the analysis and pub-
lication of already existing data.
To be effective and comprehensive, a surveillance pro-
gram should include various components investigating
different aspects of health events which serve to comple-
ment one another, such as scanning and targeted surveil-
lance approaches, outbreak investigation, archiving of
biological samples, field and laboratory studies, predict-
ive modeling and risk assessment [19,53]. Similarly, for
targeted investigations a triangulation approach, such as
the combination of antibody or pathogen surveys with
pathological investigations, or of laboratory or field in-
vestigations with questionnaire enquiries, may be useful
to access a satisfying amount of data and increase result
reliability. Different methods may also act in synergy:
presence in the fields for targeted sampling usually in-
creases disease awareness in hunters and game wardens,
who may subsequently submit more cases for scanning
surveillance; feedback from the laboratory to the fields
in the form of reports on investigated carcasses will en-
courage field partners to participate in future sampling
campaigns; teaching efforts also contribute to the suc-
cess of surveillance by increasing the interest of field
partners for health issues; conversely, data arising from
surveillance are useful for teaching purposes. Overall,
synergies not only improve the efficiency of the system,
they also permit saving resources.
Surveillance is an on-going process unlimited in time.
For this process to be efficient, it is important to work
with long-term goals in mind. Suboptimal communication
with field partners in the framework of a single survey
may compromise future studies and scanning surveillance
efforts. Furthermore, sample and data archives not only
allow retrospective investigations, they also contribute
to saving resources and increasing sample sizes in future
surveys.
Systematic collection of metadata during sampling cam-
paigns is necessary because various environmental and in-
dividual factors can influence results obtained in the
framework of surveys. Also, collection of wildlife speci-
mens is often hampered by issues related to population
management and access to the animals, resulting in a con-
venience sample. The distinction between risk factors for
infection and sampling biases is crucial. Furthermore, defi-
nitions and methods – for fieldwork, laboratory analyses
and data management – need to be standardized to allow
for a global approach to wildlife health investigations.
Overall, wildlife health investigations are associated with
numerous potential problems. These concerns should notbe viewed as insurmountable, but it is imperative that they
are considered in study design, data analysis and results
interpretation [21] (Figure 3). It is especially important to
remember that health investigations do not start in the la-
boratory. They begin in the field. And because surveillance
is carried out with the goal of taking action, resources and
efforts should not only be allocated to data collection but
should fundamentally always include data analysis and dis-
semination of information.
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